Wolchko J Scott's Form 4 filing
Fate Therapeutics Inc (FATE) · filed Jul 25, 2022
- Accession no.
- 0001209191-22-043143
- Filed
- Jul 25, 2022
- Trade date
- Jul 21-22, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.19M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wolchko J ScottCIK 0001586893 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2022 | Common Stock | MOption exerciseAcquired | +30,000 | $2.70 | +$81,000 | 461,546 | Direct | |
| Jul 21, 2022 | Common Stock | SSaleDisposed | −10,829 | $32.54 | −$352,375.66 | 450,717 | Direct | |
| Jul 21, 2022 | Common Stock | SSaleDisposed | −19,171 | $33.07 | −$633,984.97 | 431,546 | Direct | |
| Jul 22, 2022 | Common Stock | MOption exerciseAcquired | +6,246 | $2.70 | +$16,864.2 | 437,792 | Direct | |
| Jul 22, 2022 | Common Stock | SSaleDisposed | −2,923 | $31.33 | −$91,577.59 | 434,869 | Direct | |
| Jul 22, 2022 | Common Stock | SSaleDisposed | −2,703 | $32.61 | −$88,144.83 | 432,166 | Direct | |
| Jul 22, 2022 | Common Stock | SSaleDisposed | −620 | $33.28 | −$20,633.6 | 431,546 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2022 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 6,246 | Direct | |
| Jul 22, 2022 | Common Stock | MOption exerciseDisposed | −6,246 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.